Lindbrook Capital’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
APM
Lindbrook Capital's EDIT Position: Q3 2024 in Review
Lindbrook Capital sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 520 shares — an estimated $2.43K sold.
Lindbrook Capital first reported a position in EDIT in Q4 2018 and held it in 21 quarters. The position peaked at $12K in Q4 2021. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.
- Lindbrook Capital reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
- Lindbrook Capital sold 520 Editas Medicine shares in Q3 2024, an estimated $2.43K.
- Lindbrook Capital first reported a position in Editas Medicine in Q4 2018 and held it in 21 quarters.
- Lindbrook Capital's Editas Medicine position peaked at $12K in Q4 2021.
- 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.
Based on Lindbrook Capital's 13F filing for Q3 2024, filed 1 Nov 2024.